TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive NIH Budget Cut At $142 Million, NCI Could Get Small Increase Over 1981 Total; Schweiker Backs NIH Funds February 27, 1981
TCL Archive Contact Planned To Encourage Insurers To Reimburse For Cancer Screening November 28, 1975
TCL Archive Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation May 9, 2014
